Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

C-reactive protein and B-type natriuretic peptide independently predict hospitalization for heart failure after acute coronary syndromes and identify patients who benefit from intensive statin therapy in the PROVE IT-TIMI 22 trial

C-reactive protein and B-type natriuretic peptide independently predict hospitalization for heart failure after acute coronary syndromes and identify patients who benefit from intensive statin therapy in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2007; 49(9 (Suppl A)):204A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.